$OMRI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Omrix Biopharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Omrix Biopharmaceuticals, Inc.. Get notifications about new insider transactions in Omrix Biopharmaceuticals, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 25 2008 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Chief Executive Off ... | Grant | A | 0.00 | 40,000 | 0 | 2,837,103 | 2.8 M to 2.8 M (+1.43 %) |
Nov 05 2008 | OMRI | Omrix Biopharmaceu ... | Alperovitz Asaf | Chief Financial Off ... | Option Exercise | A | 13.25 | 60,000 | 795,000 | 60,000 | |
Oct 30 2008 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | President and COO | Grant | A | 0.00 | 20,000 | 0 | 27,000 | 7 K to 27 K (+285.71 %) |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Chief Executive Off ... | Option Exercise | A | 21.69 | 25,000 | 542,250 | 65,000 | |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 38,250 | |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Grant | A | 0.00 | 2,000 | 0 | 4,000 | 2 K to 4 K (+100.00 %) |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 77,634 | |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Grant | A | 0.00 | 2,000 | 0 | 119,627 | 117.6 K to 119.6 K (+1.70 %) |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 41,000 | |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Grant | A | 0.00 | 2,000 | 0 | 6,000 | 4 K to 6 K (+50.00 %) |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Option Exercise | A | 21.69 | 10,000 | 216,900 | 46,442 | |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Grant | A | 0.00 | 2,000 | 0 | 10,467 | 8.5 K to 10.5 K (+23.62 %) |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | ELLBERGER LARRY | Director | Option Exercise | A | 21.69 | 15,000 | 325,350 | 46,000 | |
Sep 05 2008 | OMRI | Omrix Biopharmaceu ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 3,000 | 0 | 5,000 | 2 K to 5 K (+150.00 %) |
May 30 2008 | OMRI | Omrix Biopharmaceu ... | MCNAMARA PAMELA W | Director | Option Exercise | A | 15.16 | 20,000 | 303,200 | 0 | |
May 30 2008 | OMRI | Omrix Biopharmaceu ... | MCNAMARA PAMELA W | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Apr 02 2008 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | President and COO | Buy | P | 14.50 | 2,000 | 29,000 | 2,000 | 0 to 2 K |
Mar 28 2008 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Buy | P | 13.65 | 1,500 | 20,475 | 4,000 | 2.5 K to 4 K (+60.00 %) |
Mar 28 2008 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Buy | P | 13.64 | 500 | 6,822 | 2,500 | 2 K to 2.5 K (+25.00 %) |
Mar 26 2008 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Buy | P | 13.59 | 7,800 | 106,002 | 115,627 | 107.8 K to 115.6 K (+7.23 %) |
Mar 21 2008 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Buy | P | 12.02 | 8,250 | 99,205 | 107,827 | 99.6 K to 107.8 K (+8.29 %) |
Mar 21 2008 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Buy | P | 12.24 | 13,940 | 170,567 | 99,577 | 85.6 K to 99.6 K (+16.28 %) |
Mar 20 2008 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Chief Executive Off ... | Buy | P | 12.10 | 26,400 | 319,527 | 2,797,103 | 2.8 M to 2.8 M (+0.95 %) |
Mar 20 2008 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Chief Executive Off ... | Buy | P | 12.31 | 53,600 | 659,666 | 2,770,703 | 2.7 M to 2.8 M (+1.97 %) |
Mar 18 2008 | OMRI | Omrix Biopharmaceu ... | Droppert V. Marc | Executive Vice Pres ... | Buy | P | 12.48 | 4,000 | 49,920 | 4,000 | 0 to 4 K |
Jan 14 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Option Exercise | S | 30.00 | 345 | 10,350 | 0 | ||
Jan 14 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Option Exercise | S | 30.00 | 145 | 4,350 | 345 | ||
Jan 14 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Option Exercise | S | 30.00 | 10 | 300 | 490 | ||
Jan 09 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Option Exercise | S | 30.00 | 500 | 15,000 | 500 | ||
Jan 07 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Sell | S | 34.00 | 32,665 | 1,110,610 | 0 | 32.7 K to 0 (-100.00 %) | |
Jan 07 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Buy | M | 6.19 | 32,665 | 202,196 | 32,665 | 0 to 32.7 K | |
Jan 04 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Option Exercise | M | 6.19 | 70,091 | 433,863 | 32,665 | ||
Jan 04 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Sell | S | 34.02 | 4,546 | 154,655 | 0 | 4.5 K to 0 (-100.00 %) | |
Jan 04 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Buy | M | 13.75 | 4,546 | 62,508 | 4,546 | 0 to 4.5 K | |
Jan 04 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Sell | S | 34.01 | 6,335 | 215,453 | 0 | 6.3 K to 0 (-100.00 %) | |
Jan 04 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Buy | M | 6.19 | 6,335 | 39,214 | 6,335 | 0 to 6.3 K | |
Jan 04 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Sell | S | 34.45 | 70,091 | 2,414,635 | 0 | 70.1 K to 0 (-100.00 %) | |
Jan 04 2008 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Buy | M | 6.19 | 70,091 | 433,863 | 70,091 | 0 to 70.1 K | |
Dec 13 2007 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Sell | S | 38.00 | 9,091 | 345,458 | 0 | 9.1 K to 0 (-100.00 %) |
Dec 13 2007 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Buy | M | 21.34 | 9,091 | 194,002 | 9,091 | 0 to 9.1 K |
Nov 30 2007 | OMRI | Omrix Biopharmaceu ... | Droppert V. Marc | Executive Vice Pres ... | Option Exercise | A | 37.08 | 60,000 | 2,224,800 | 0 | |
Nov 09 2007 | OMRI | Omrix Biopharmaceu ... | Prado Nanci | General Counsel | Option Exercise | M | 16.33 | 9,000 | 146,970 | 27,000 | |
Nov 09 2007 | OMRI | Omrix Biopharmaceu ... | Prado Nanci | General Counsel | Sell | S | 37.51 | 9,000 | 337,590 | 0 | 9 K to 0 (-100.00 %) |
Nov 09 2007 | OMRI | Omrix Biopharmaceu ... | Prado Nanci | General Counsel | Buy | M | 16.33 | 9,000 | 146,970 | 9,000 | 0 to 9 K |
Oct 02 2007 | OMRI | Omrix Biopharmaceu ... | Stancic Ana | Chief Financial Off ... | Option Exercise | A | 35.67 | 60,000 | 2,140,200 | 0 | |
Oct 02 2007 | OMRI | Omrix Biopharmaceu ... | Stancic Ana | Chief Financial Off ... | Grant | A | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
Aug 14 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Option Exercise | M | 12.27 | 2,750 | 33,743 | 8,250 | |
Aug 14 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Sell | S | 29.49 | 2,750 | 81,098 | 2,000 | 4.8 K to 2 K (-57.89 %) |
Aug 14 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Buy | M | 12.27 | 2,750 | 33,743 | 4,750 | 2 K to 4.8 K (+137.50 %) |
Jun 29 2007 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Option Exercise | M | 12.27 | 2,750 | 33,743 | 8,250 | |
Jun 29 2007 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Buy | M | 12.27 | 2,750 | 33,743 | 8,467 | 5.7 K to 8.5 K (+48.10 %) |
Jun 19 2007 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Senior VP and CFO | Option Exercise | P | 30.00 | 1,000 | 30,000 | 1,000 | |
Jun 08 2007 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Option Exercise | M | 10.00 | 2,717 | 27,170 | 8,192 | |
Jun 08 2007 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Buy | M | 10.00 | 2,717 | 27,170 | 5,717 | 3 K to 5.7 K (+90.57 %) |
Jun 06 2007 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Sell | S | 34.50 | 2,000 | 69,000 | 3,000 | 5 K to 3 K (-40.00 %) |
Jun 05 2007 | OMRI | Omrix Biopharmaceu ... | PRICE FREDRIC D | Director | Option Exercise | M | 6.19 | 49,000 | 303,188 | 60,091 | |
Jun 05 2007 | OMRI | Omrix Biopharmaceu ... | PRICE FREDRIC D | Director | Sell | S | 33.80 | 49,000 | 1,656,200 | 7,000 | 56 K to 7 K (-87.50 %) |
Jun 05 2007 | OMRI | Omrix Biopharmaceu ... | PRICE FREDRIC D | Director | Buy | M | 6.19 | 49,000 | 303,188 | 56,000 | 7 K to 56 K (+700.00 %) |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Option Exercise | A | 33.10 | 20,000 | 662,000 | 0 | |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Grant | A | 0.00 | 2,000 | 0 | 85,637 | 83.6 K to 85.6 K (+2.39 %) |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Option Exercise | A | 33.10 | 20,000 | 662,000 | 0 | |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Option Exercise | A | 33.10 | 20,000 | 662,000 | 0 | |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | PRICE FREDRIC D | Director | Option Exercise | A | 33.10 | 20,000 | 662,000 | 0 | |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | PRICE FREDRIC D | Director | Grant | A | 0.00 | 2,000 | 0 | 7,000 | 5 K to 7 K (+40.00 %) |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Option Exercise | A | 33.10 | 20,000 | 662,000 | 0 | |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Grant | A | 0.00 | 2,000 | 0 | 3,000 | 1,000 to 3 K (+200.00 %) |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | ELLBERGER LARRY | Director | Option Exercise | A | 33.10 | 20,000 | 662,000 | 0 | |
Jun 01 2007 | OMRI | Omrix Biopharmaceu ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Mar 29 2007 | OMRI | Omrix Biopharmaceu ... | Tang Joseph | General Manager, As ... | Option Exercise | A | 38.08 | 16,000 | 609,280 | 0 | |
Mar 29 2007 | OMRI | Omrix Biopharmaceu ... | Tang Joseph | General Manager, As ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jan 19 2007 | OMRI | Omrix Biopharmaceu ... | PRICE FREDRIC D | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Senior VP and CFO | Option Exercise | A | 34.75 | 20,000 | 695,000 | 0 | |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | Burshtine Michael | Senior VP and CFO | Grant | A | 0.00 | 5,000 | 0 | 12,576 | 7.6 K to 12.6 K (+66.00 %) |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Option Exercise | A | 34.75 | 20,000 | 695,000 | 0 | |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | SAFFERSTEIN HAROLD | VP, Business Develo ... | Option Exercise | A | 34.75 | 5,000 | 173,750 | 0 | |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Director | Option Exercise | A | 34.75 | 11,000 | 382,250 | 0 | |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | RAKIN KEVIN | Director | Option Exercise | A | 34.75 | 11,000 | 382,250 | 0 | |
Jan 18 2007 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Pres., Chief Execut ... | Sell | S | 30.08 | 102,391 | 3,079,921 | 1,210,262 | 1.3 M to 1.2 M (-7.80 %) |
Dec 20 2006 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Pres., Chief Execut ... | Option Exercise | A | 31.08 | 40,000 | 1,243,200 | 40,000 | |
Dec 20 2006 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Pres., Chief Execut ... | Sell | S | 30.08 | 682,606 | 20,532,788 | 1,312,653 | 2 M to 1.3 M (-34.21 %) |
Dec 20 2006 | OMRI | Omrix Biopharmaceu ... | Taub Robert | Pres., Chief Execut ... | Grant | A | 0.00 | 36,364 | 0 | 1,534,113 | 1.5 M to 1.5 M (+2.43 %) |
Nov 21 2006 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Gift | G | 0.00 | 1,000 | 0 | 3,000 | 4 K to 3 K (-25.00 %) |
Dec 20 2006 | OMRI | Omrix Biopharmaceu ... | Romagnoli Philippe | Vice President and ... | Sell | S | 30.08 | 67,394 | 2,027,212 | 83,637 | 151 K to 83.6 K (-44.62 %) |
Nov 13 2006 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Option Exercise | M | 2.75 | 30,000 | 82,500 | 42,728 | |
Nov 13 2006 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Option Exercise | M | 16.97 | 12,728 | 215,994 | 0 | |
Nov 13 2006 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Sell | S | 22.85 | 42,728 | 976,335 | 0 | 42.7 K to 0 (-100.00 %) |
Nov 13 2006 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Buy | M | 16.97 | 12,728 | 215,994 | 42,728 | 30 K to 42.7 K (+42.43 %) |
Nov 13 2006 | OMRI | Omrix Biopharmaceu ... | Mashiach Nissim | Senior VP, Operatio ... | Buy | M | 2.75 | 30,000 | 82,500 | 30,000 | 0 to 30 K |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | Akers Joseph A | Director | Option Exercise | A | 20.24 | 11,000 | 222,640 | 0 | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | BB BIOVENTURES L P | Sell | J | 0.00 | 1,567,823 | 0 | 0 | 1.6 M to 0 (-100.00 %) | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | STEINMETZ MICHAEL | Buy | J | 0.00 | 29,143 | 0 | 58,884 | 29.7 K to 58.9 K (+97.99 %) | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | STEINMETZ MICHAEL | Sell | J | 0.00 | 1,567,823 | 0 | 0 | 1.6 M to 0 (-100.00 %) | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | Buy | J | 0.00 | 60,640 | 0 | 60,640 | 0 to 60.6 K | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | Sell | J | 0.00 | 1,567,823 | 0 | 0 | 1.6 M to 0 (-100.00 %) | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | GADICKE ANSBERT | Buy | J | 0.00 | 28,730 | 0 | 28,730 | 0 to 28.7 K | |
Nov 06 2006 | OMRI | Omrix Biopharmaceu ... | GADICKE ANSBERT | Sell | J | 0.00 | 1,567,823 | 0 | 0 | 1.6 M to 0 (-100.00 %) | |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.76 | 15,095 | 298,224 | 0 | 15.1 K to 0 (-100.00 %) |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.95 | 14,225 | 283,789 | 15,095 | 29.3 K to 15.1 K (-48.52 %) |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Gift | G | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Sell | S | 19.76 | 21,402 | 422,829 | 10,000 | 31.4 K to 10 K (-68.15 %) |
Oct 25 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Sell | S | 19.95 | 30,483 | 608,136 | 31,402 | 61.9 K to 31.4 K (-49.26 %) |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | GADICKE ANSBERT | 10% Owner | Buy | J | 0.00 | 29,320 | 0 | 29,320 | 0 to 29.3 K |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | GADICKE ANSBERT | 10% Owner | Sell | J | 0.00 | 1,600,000 | 0 | 1,567,823 | 3.2 M to 1.6 M (-50.51 %) |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | STEINMETZ MICHAEL | 10% Owner | Buy | J | 0.00 | 29,741 | 0 | 29,741 | 0 to 29.7 K |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | STEINMETZ MICHAEL | 10% Owner | Sell | J | 0.00 | 1,600,000 | 0 | 1,567,823 | 3.2 M to 1.6 M (-50.51 %) |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | BB BIOVENTURES L P | 10% Owner | Sell | J | 0.00 | 1,600,000 | 0 | 1,567,823 | 3.2 M to 1.6 M (-50.51 %) |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Buy | J | 0.00 | 61,885 | 0 | 61,885 | 0 to 61.9 K |
Oct 19 2006 | OMRI | Omrix Biopharmaceu ... | EVNIN LUKE | 10% Owner | Sell | J | 0.00 | 1,600,000 | 0 | 1,567,823 | 3.2 M to 1.6 M (-50.51 %) |
Sep 07 2006 | OMRI | Omrix Biopharmaceu ... | Prado Nanci | Vice Pres. & Genera ... | Option Exercise | A | 16.33 | 36,000 | 587,880 | 0 | |
Aug 11 2006 | OMRI | Omrix Biopharmaceu ... | ELLBERGER LARRY | Director | Option Exercise | A | 12.04 | 11,000 | 132,440 | 0 | |
Jun 29 2006 | OMRI | Omrix Biopharmaceu ... | PRICE FREDRIC D | Director | Option Exercise | A | 12.27 | 11,000 | 134,970 | 120,091 | |
Jun 29 2006 | OMRI | Omrix Biopharmaceu ... | COTTER DOUGLAS A | Director | Option Exercise | A | 12.27 | 11,000 | 134,970 | 21,909 | |
Jun 29 2006 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Option Exercise | A | 12.27 | 11,000 | 134,970 | 21,909 | |
Jun 29 2006 | OMRI | Omrix Biopharmaceu ... | St Peter Steven | Director | Option Exercise | A | 12.27 | 11,000 | 134,970 | 11,000 | |
May 17 2006 | OMRI | Omrix Biopharmaceu ... | SAFFERSTEIN HAROLD | Director | Option Exercise | A | 10.00 | 36,364 | 363,640 | 0 | |
May 17 2006 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Option Exercise | A | 10.00 | 10,909 | 109,090 | 0 | |
May 17 2006 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Buy | P | 14.20 | 1,000 | 14,200 | 4,000 | 3 K to 4 K (+33.33 %) |
May 16 2006 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Buy | P | 14.57 | 1,000 | 14,570 | 2,000 | 1,000 to 2 K (+100.00 %) |
Apr 26 2006 | OMRI | Omrix Biopharmaceu ... | Horowitz Bernard | Director | Buy | P | 10.24 | 1,000 | 10,240 | 1,000 | 0 to 1,000 |
Page: 1